1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
Loading...
Loading...
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Capital Structure
3. Valuation
Discussion
Symbol
COAG
Event Date
2026-05-01
Sector
Health Care
Subsector
Biotechnology
Offer Range
—
Shares Offered
15M
Shares Outstanding Pre-IPO
946K
42.44M
—
Implied Upside vs Midpoint
$00.00Description
—
Post-IPO economic shares by class.
| Class | Shares | % Economic |
|---|---|---|
Ordinary shares (DKK 1 par value) / Common stock (public IPO class) (listed) | 42.44M | 100.0% |
| Total economic shares | 42.44M | 100% |
Series Seed convertible preference shares (DKK 1 par value) Pre-conversion — already in the listed class | 23.34K |
Series A convertible preference shares (DKK 1 par value) Pre-conversion — already in the listed class | 225.87K |
Series B convertible preference shares (DKK 1 par value) Pre-conversion — already in the listed class | 442.2K |
Series C convertible preference shares (DKK 1 par value) Pre-conversion — already in the listed class | 512.99K |